0.20
-0.0038(-1.85%)
Currency In USD
Address
999 West Broadway
Vancouver, BC V5Z 1K5
Canada
Phone
17783310962
Website
Sector
Healthcare
Industry
Biotechnology
Employees
35
First IPO Date
March 13, 2015
| Name | Title | Pay | Year Born |
| Dr. David Ross Parkinson M.D. | President, Chief Executive Officer & Director | 894,018 | 1950 |
| Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA | Chief Financial Officer | 646,765 | 1957 |
| Dr. Alessandra Cesano M.D., Ph.D. | Chief Medical Officer & Executive Vice President | 678,282 | 1961 |
| Mr. Peter A. Virsik M.B.A., M.S. | Executive Vice President & Chief Operating Officer | 696,191 | 1971 |
| Chandtip Chandhasin | Executive | 0 | N/A |
| Erin Rudsinski | Executive | 0 | N/A |
| Nkengyal Barber | Executive | 0 | N/A |
| Erica Osbourne | Executive | 0 | N/A |
| Neil Thapar | Executive | 0 | N/A |
| Loleta Harris | Executive | 0 | N/A |
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.